Abstract
Recently, antimicrobial peptides (AMPs) have emerged as a promising anticancer remedy. Negative charge of the bacterial membranes gives some measure for selectivity of cationic AMPs, since mammalian cell membranes are largely zwitterionic. Accumulating evidence indicates that lipid composition of the cancer cell membranes is different from a healthy cell, displaying net membrane surface negative charge. Understanding the nature of the negatively charged membrane domains could provide a new basis for anticancer therapy drug design using antimicrobial peptides or their synthetic mimics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
